Traws Pharma Announces Progress in Developing Tivoxavir Marboxil for H5N1 Bird Flu
January 2, 2025
Traws Pharma, a clinical-stage biopharmaceutical company developing oral small molecule therapies for the treatment of respiratory viral diseases, today announced progress in the development of